| 1 |
陈骏，毛谅，何健, 等. 第8版《美国癌症联合会肿瘤分期手册》肝内胆管细胞癌TNM分期解读 [J]. 中华消化外科杂志, 2017, 16(4): 330-335.
|
| 2 |
Park HJ, Kim YK, Park MJ, et al. Small intrahepatic mass-forming cholangiocarcinoma: target sign on diffusion-weighted imaging for differentiation from hepatocellular carcinoma [J]. Abdom Imaging, 2013, 38(4): 793-801.
|
| 3 |
Fattach HE, Dohan A, Guerrache Y, et al. Intrahepatic and hilar mass-forming cholangiocarcinoma: Qualitative and quantitative evaluation with diffusion-weighted MR imaging [J]. Eur J Radiol, 2015, 84(8): 1444-1451.
|
| 4 |
Peng NF, Li LQ, Qin X, et al. Evaluation of risk factors and clinicopathologic features for intrahepatic cholangiocarcinoma in Southern China: a possible role of hepatitis B virus [J]. Ann Surg Oncol, 2011, 18(5): 1258-1266.
|
| 5 |
Wang C, Jing H, Sha D, et al. HBV-associated intrahepatic cholangiocarcinoma with high serum alpha-fetoprotein: a case report with review of literature [J]. BMC Infect Dis, 2016, 16: 295.
|
| 6 |
Wu ZF, Yang N, Li DY, et al. Characteristics of intrahepatic cholangiocarcinoma in patients with hepatitis B virus infection: clinicopathologic study of resected tumours [J]. J Viral Hepat, 2013, 20(5): 306-310.
|
| 7 |
Lee CH, Chang CJ, Lin YJ, et al. Viral hepatitis-associated intrahepatic cholangiocarcinoma shares common disease processes with hepatocellular carcinoma [J]. Br J Cancer, 2009, 100(11): 1765-1770.
|
| 8 |
Mao K, Liu J, Sun J, et al. Patterns and prognostic value of lymph node dissection for resected perihilar cholangiocarcinoma [J]. J Gastroenterol Hepatol, 2016, 31(2): 417-426.
|
| 9 |
Igami T, Ebata T, Yokoyama Y, et al. Staging of peripheral-type intrahepatic cholangiocarcinoma: appraisal of the new TNM classification and its modifications [J]. World J Surg, 2011, 35(11): 2501-2509.
|
| 10 |
黎蕴通，曾永毅. 肝内胆管癌的腹腔淋巴结清扫 [J]. 临床外科杂志, 2017, 25(6): 417-419.
|
| 11 |
Lei Z, Xia Y, Si A, et al. Antiviral therapy improves survival in patients with HBV infection and intrahepatic cholangiocarcinoma undergoing liver resection [J]. J Hepatol, 2018, 68(4): 655-662.
|
| 12 |
Lee TY, Hsu YC, Yu SH, et al. Effect of Nucleos(t)ide Analogue Therapy on Risk of Intrahepatic Cholangiocarcinoma in Patients With Chronic Hepatitis B [J]. Clin Gastroenterol Hepatol, 2018, 16(6): 947-954. e4.
|
| 13 |
Lin YK, Hsieh MC, Wang WW, et al. Outcomes of adjuvant treatments for resectable intrahepatic cholangiocarcinoma: Chemotherapy alone, sequential chemoradiotherapy, or concurrent chemoradiotherapy [J]. Radiother Oncol, 2018, 128(3): 575-583.
|
| 14 |
Fisher SB, Patel SH, Kooby DA, et al. Lymphovascular and perineural invasion as selection criteria for adjuvant therapy in intrahepatic cholangiocarcinoma: a multi-institution analysis [J]. HPB (Oxford), 2012, 14(8): 514-522.
|
| 15 |
Salimon M, Prieux-Klotz C, Tougeron D, et al. Gemcitabine plus platinum-based chemotherapy for first-line treatment of hepatocholangiocarcinoma: an AGEO French multicentre retrospective study [J]. Br J Cancer, 2018, 118(3): 325-330.
|
| 16 |
Valle J, Wasan H, Palmer DH, et al. Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer [J]. N Engl J Med, 2010, 362(14): 1273-1281.
|
| 17 |
Giorgio A, Calisti G, DE Stefano G, et al. Radiofrequency ablation for intrahepatic cholangiocarcinoma: retrospective analysis of a single centre experience [J]. Anticancer Res, 2011, 31(12): 4575-4580.
|
| 18 |
Choi SB, Kim KS, Choi JY, et al. The prognosis and survival outcome of intrahepatic cholangiocarcinoma following surgical resection: association of lymph node metastasis and lymph node dissection with survival [J]. Ann Surg Oncol, 2009, 16(11): 3048-3056.
|
| 19 |
Wu ZF, Zhang HB, Yang N, et al. Postoperative adjuvant transcatheter arterial chemoembolisation improves survival of intrahepatic cholangiocarcinoma patients with poor prognostic factors: results of a large monocentric series [J]. Eur J Surg Oncol, 2012, 38(7): 602-610.
|
| 20 |
Mosquera C, Johnson HM, Mitsakos AT, et al. Predictive Value of Preoperative Serum CA19-9 on Margin Status [J]. Am Surg, 2019, 85(9): 965-972.
|